News
http://www.cysticfibrosis.ca/wp-content/themes/Cystic-Fibrosis-Canada/img/FB_Share_Image.jpg
DONATECLOSE
GENERAL DONATIONS
MONTHLY
IN HONOUR
IN MEMORY
NEWS AND MEDIA
Stay UP TO DATE on the latest news, announcements
and reports regarding cystic fibrosis in Canada

FEATURED NEWS

We are pleased to share news with you that as of today, cystic fibrosis patients ages six and above with the G551D mutation in Manitoba will now have access to Kalydeco. Manitoba is the fifth pan-Canadian Pricing Alliance (PCPA) member province to…Read More
Wednesday, October 15, 2014 (TORONTO, ONTARIO) — The median age of survival for Canadian cystic fibrosis (CF) patients continues to increase in an upward trend – currently estimated to be 50.9 years of age, it is among the highest in the world.…Read More
CF patients in Nova Scotia with the G551D gene mutation now have access to KALYDECO®, as a result of an agreement between the drug manufacturer and the Nova Scotia government. Read the update from CBC news.Read More
By Jim Mountain, Chair, Board of Directors on October 9, 2014 I am pleased to announce the appointment of Norma Beauchamp as President and CEO of Cystic Fibrosis Canada. She joins us on Monday, November 3rd, 2014. An accomplished business and…Read More
We are pleased to share news with you that as of October 1st, cystic fibrosis patients ages six and above in Nova Scotia with the G551D mutation now have access to Kalydeco. Nova Scotia is the fourth pan-Canadian Pricing Alliance (PCPA) member…Read More
SHARE THIS PAGE